Vimarsana
Biggest News Aggregation in the World

Mofo Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mofo Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mofo Life Sciences Today - Breaking & Trending Today

Non-Lab Diagnostics: FDA Regulatory Considerations | MoFo Life Sciences - Vimarsana News

Non-Lab Diagnostics: FDA Regulatory Considerations | MoFo Life Sciences

The advent of the COVID-19 rapid antigen test launched at-home diagnostics to the forefront of conversation in the life sciences industry. Many believe this is only the beginning. As...

At-Home Diagnostics Articles: Non-Lab Diagnostics: Supply, Manufacturing, And Distribution Agreements | MoFo Life Sciences - Vimarsana News

At-Home Diagnostics Articles: Non-Lab Diagnostics: Supply, Manufacturing, And Distribution Agreements | MoFo Life Sciences

The advent of the COVID-19 rapid antigen test launched at-home diagnostics to the forefront of conversation in the life sciences industry. Many believe this is only the beginning. As...

New Regulations Rooted In Evidence: Looking Back On How EPA And USDA Updated Engineered Plant Regulations And Labeling In 2023 | MoFo Life Sciences - Vimarsana News

New Regulations Rooted In Evidence: Looking Back On How EPA And USDA Updated Engineered Plant Regulations And Labeling In 2023 | MoFo Life Sciences

Alongside rapid advances in biotechnology that are improving fine-tuned genetic engineering in plants, regulation for such plants is also rapidly evolving, including several important...

USPTO Enablement Guidelines After Amgen V. Sanofi | MoFo Life Sciences - Vimarsana News

USPTO Enablement Guidelines After Amgen V. Sanofi | MoFo Life Sciences

On January 10, 2024, the USPTO released new Guidelines for Assessing Enablement in Utility Applications and Patents in View of the Supreme Court Decision in Amgen Inc. et al. v. Sanofi...

2024 Regulatory, Compliance, and Enforcement Predictions for Life Sciences Companies | Morrison & Foerster LLP - Vimarsana News

2024 Regulatory, Compliance, and Enforcement Predictions for Life Sciences Companies | Morrison & Foerster LLP

The year 2023 was a busy one for regulatory, compliance, and enforcement developments in the healthcare and life sciences industries, and 2024 promises to be even busier. We tapped...